Literature DB >> 9187601

Extensive tyrosine nitration in human myocardial inflammation: evidence for the presence of peroxynitrite.

N W Kooy1, S J Lewis, J A Royall, Y Z Ye, D R Kelly, J S Beckman.   

Abstract

OBJECTIVES: Production of nitric oxide via the cytokine-mediated activation of myocardial inducible nitric oxide synthase decreases myocardial contractility. Whether myocardial dysfunction is mediated directly by nitric oxide or indirectly through the formation of secondary reaction products, such as peroxynitrite, has not been established. Peroxynitrite, but not nitric oxide, reacts with the phenolic ring of tyrosine to form the stable product 3-nitro-L-tyrosine. Demonstration of tissue nitrotyrosine residues, therefore, infers the presence of peroxynitrite or related nitrogen-centered oxidants.
DESIGN: Retrospective analysis of human autopsy specimens.
SETTING: University pathology and basic science laboratories. PATIENTS: Formalin-fixed, paraffin-embedded myocardial tissue samples were obtained from 11 patients with a diagnosis of sepsis, seven patients with a diagnosis of viral myocarditis, and five control patients without clinical or pathologic cardiac disease.
INTERVENTIONS: None.
MEASUREMENTS AND MAIN RESULTS: Specific antibodies to nitrotyrosine were utilized to detect nitrotyrosine residues in human autopsy specimens. Cardiac tissue obtained from patients with myocarditis or sepsis demonstrated intense nitrotyrosine immunoreactivity in the endocardium, myocardium, and coronary vascular endothelium and smooth muscle. In contrast, connective tissue elements were without appreciable immunohistochemical staining. Nitrotyrosine antibody binding was blocked by coincubation with nitrotyrosine or nitrated bovine serum albumin, but not by aminotyrosine, phosphotyrosine, or bovine serum albumin. In situ reduction of tissue nitrotyrosine to aminotyrosine by sodium hydrosulfite also blocked antibody binding. Densitometric analysis of nitrotyrosine immunoreactivity demonstrated significantly higher values for specimens from myocarditis and sepsis patients when compared with control tissue specimens.
CONCLUSION: These results demonstrate the formation of peroxynitrite within the myocardium during inflammatory disease states, suggesting a role for peroxynitrite in inflammation-associated myocardial dysfunction.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9187601     DOI: 10.1097/00003246-199705000-00017

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  43 in total

1.  Intracellular distribution of peroxynitrite during doxorubicin cardiomyopathy: evidence for selective impairment of myofibrillar creatine kinase.

Authors:  Michael J Mihm; Fushun Yu; David M Weinstein; Peter J Reiser; John Anthony Bauer
Journal:  Br J Pharmacol       Date:  2002-02       Impact factor: 8.739

Review 2.  Measuring reactive species and oxidative damage in vivo and in cell culture: how should you do it and what do the results mean?

Authors:  Barry Halliwell; Matthew Whiteman
Journal:  Br J Pharmacol       Date:  2004-05       Impact factor: 8.739

3.  Acute O-GlcNAcylation prevents inflammation-induced vascular dysfunction.

Authors:  Rob H P Hilgers; Dongqi Xing; Kaizheng Gong; Yiu-Fai Chen; John C Chatham; Suzanne Oparil
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-07-09       Impact factor: 4.733

4.  The effect of neighboring methionine residue on tyrosine nitration and oxidation in peptides treated with MPO, H2O2, and NO2(-) or peroxynitrite and bicarbonate: role of intramolecular electron transfer mechanism?

Authors:  Hao Zhang; Jacek Zielonka; Adam Sikora; Joy Joseph; Yingkai Xu; B Kalyanaraman
Journal:  Arch Biochem Biophys       Date:  2008-11-24       Impact factor: 4.013

Review 5.  Pathophysiological roles of peroxynitrite in circulatory shock.

Authors:  Csaba Szabó; Katalin Módis
Journal:  Shock       Date:  2010-09       Impact factor: 3.454

Review 6.  Pathophysiological role of oxidative stress in systolic and diastolic heart failure and its therapeutic implications.

Authors:  Thomas Münzel; Tommaso Gori; John F Keaney; Christoph Maack; Andreas Daiber
Journal:  Eur Heart J       Date:  2015-07-04       Impact factor: 29.983

7.  Antioxidant enriched enteral nutrition and oxidative stress after major gastrointestinal tract surgery.

Authors:  Mireille F M van Stijn; Gerdien C Ligthart-Melis; Petra G Boelens; Peter G Scheffer; Tom Teerlink; Jos W R Twisk; Alexander P J Houdijk; Paul A M van Leeuwen
Journal:  World J Gastroenterol       Date:  2008-12-07       Impact factor: 5.742

8.  Matrix metalloproteinase inhibitors attenuate endotoxemia induced cardiac dysfunction: a potential role for MMP-9.

Authors:  Manoj M Lalu; Cindy Q Gao; Richard Schulz
Journal:  Mol Cell Biochem       Date:  2003-09       Impact factor: 3.396

9.  Multiple risk markers for atherogenesis associated with chronic inflammation are detectable in patients with renal stones.

Authors:  Kuo-Chien Tsao; Tsu-Lan Wu; Pi-Yueh Chang; Chien-Feng Sun; Lily L Wu; James T Wu
Journal:  J Clin Lab Anal       Date:  2007       Impact factor: 2.352

10.  Indomethacin potentiates acetylcholine-induced vasodilation by increasing free radical production.

Authors:  Antonella De Angelis; Barbara Rinaldi; Annalisa Capuano; Francesco Rossi; Amelia Filippelli
Journal:  Br J Pharmacol       Date:  2004-07-20       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.